Davis's Drug Guide
rozanolixizumab
General
Pronunciation:
roz-an-oh-lix-iz-ue-mab
Trade Name(s)
- Rystiggo
Ther. Class.
antimyasthenics
Pharm. Class.
temporary class
neonatal Fc receptor blockermonoclonal antibodies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Rozanolixizumab." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Emergency Central, emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580079/all/rozanolixizumab.
Vallerand AHA, Sanoski CAC, . Rozanolixizumab. Davis's Drug Guide. F.A. Davis Company; 2025. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580079/all/rozanolixizumab. Accessed April 20, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Rozanolixizumab. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580079/all/rozanolixizumab
Vallerand AHA, Sanoski CAC, . Rozanolixizumab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 April 20]. Available from: https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580079/all/rozanolixizumab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - rozanolixizumab
ID - 3580079
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580079/all/rozanolixizumab
PB - F.A. Davis Company
ET - 19
DB - Emergency Central
DP - Unbound Medicine
ER -
